While CDK19 is downregulated in leukemia, lymphoma and esophageal cancer, CDK8 is overexpressed and amplified in ~50% of colon cancers suggesting a selective role of CDK8 in this type of tumors (Firestein et al., 2008; Morris et al., 2008). This evidence concerns the gene CDK8 and lymphoma.